NCT03010735View on ClinicalTrials.gov

Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

December 31, 2017

Conditions
Kidney Failure, Chronic
Interventions
DIETARY_SUPPLEMENT

probiotics

Daily take 4.0E+10 CFU of probiotics

DIETARY_SUPPLEMENT

Placebo

Trial Locations (3)

100029

Beijing Anzhen Hospital, Beijing

100039

General Hospital of Chinese Armed Police Forces, Beijing

100049

Peking University Aerospace Centre Hospital, Beijing

All Listed Sponsors
collaborator

Peking University Aerospace Center Hospital

OTHER

collaborator

General Hospital of Chinese Armed Police Forces

OTHER

collaborator

Beijing Anzhen Hospital

OTHER

collaborator

Beijing Biostats Technology Co. Ltd.

UNKNOWN

collaborator

Beijing Heyiyuan Biotech Co. Ltd.

OTHER

lead

China Agricultural University

OTHER

NCT03010735 - Effects of Probiotics on the Patients With End Stage Renal Disease (ESRD) | Biotech Hunter | Biotech Hunter